| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |